0000000000947374
AUTHOR
Anna Musciotto
STORIA NATURALE DI OSTEONECROSI DA BIFOSFONATI PER OS. A CASE REPORT
Biostimolazione mediante laser a diodi per il trattamento delle osteonecrosi dei mascellari da bifosfonati. Pilot Trial
Halitosis and HCV-related liver disease:true association
Protocol of BRONJ prevention: successful use of antiseptics during oral surgical procedures
Aim: The overall prevention and treatment of Bisphosphonates related osteonecrosis of the jaws (BRONJ) have been the goals of our project structured (labelled PROMaB) within the hospital AOUP “P. Giaccone” (Italy) in order to make better quality life of patients in therapy with amminobisphosphonates (NBP). Material and Methods: Among all procedures, in case of preprogrammed oral surgical procedure, oral antimicrobial rinses (i.e. chlorexidine 0,2% mouthwash and 0,5% gel, three times/day) plus oral systemic antibiotic therapy –e.g. amoxicilin/clavulanate- have been used to reduce the risk of BRONJ in secondary prevention (1 day before and 6 days after). Three hundred and twenty-one patients …
Findings of osteonecrosis of the jaw under combined bisphosphonate and antiangiogenic therapies: an emergent problem?
Nuove prospettive nel Managment dei pazienti con osteonecrosi dei mascellari da bifosfonati
ALITOSI - UPDATE IN TEMA DI EZIOLOGIA E CLINICA
Bifosfonati per osteoporosi e rischio di osteonecrosi dei mascellari: novità in termini di clinica e management
OralChroma vs Halimeter.Accuratezza diagnostica a confronto:studio pilota
Bisphosphonate-related osteonecrosis of the jaw (BRONJ): run dental management designs and issues in diagnosis
Recently, jawbone osteonecrosis has been largely reported as a potential adverse effect of bisphosphonate (BP) administration. Because of the peculiar pharmacokinetic and pharmacodynamic features of the BF (mainly for i.v. administration), their efficacy and large use, some major issues have to be taken into account extendedly both by oncologists and by dentists: 1) therapeutic dental protocol for patients with diagnosis of bisphosphonate-related osteonecrosis of the jaw (BRONJ); 2) dental strategies for patients in former or current i.v. BF treatment and in absence of BRONJ signs; 3) strategies for patients before i.v. BF treatment. Clinical features and guidelines for the management of th…
ALITOSI ed EPATOPATIE: vera associazione o luogo comune? Studio pilota
Biostimolazione mediante laser a diodi nel trattamento delle osteonecrosi dei mascellari da bifosfonati.
Osteoporosi e Bifosfonati per os:nuova emergenza per l'Odontoiatra
Osteoporosi-malattie dello scheletro e bifosfonati per os: rischio limitato ma emergente di osteonecrosi dei mascellari. Task force (Promab) e proposta di linee guida per la prevenzione primaria e secondaria OSTEOPOROSIS-SKELETAL DISEASES AND ORAL BIPHOSPHONATES: LOW BUT EMERGING RISK OF OSTEONECROSIS OF JAWS. TASK-FORCE (PROMAB) AND PROPOSAL OF RECOMMENDATIONS FOR PRIMARY AND SECONDARY PREVENTION
Altosi ed Epatopatie: vera associazione o luogo comune?Studio pilota
L'estetica del sorriso ed il controllo dell'alito
Nonexposed Variant of Bisphosphonate-associated Osteonecrosis of the Jaw: A Case Series
Abstract Purpose To report a case series of patients with the nonexposed variant of bisphosphonate-associated osteonecrosis of the jaw—a form of jaw osteonecrosis that does not manifest with necrotic bone exposure/mucosal fenestration. Methods Among 332 individuals referred to 5 clinical centers in Europe because of development of jawbone abnormalities after or during exposure to bisphosphonates, we identified a total of 96 patients who presented with the nonexposed variant of osteonecrosis. Relevant data were obtained via clinical notes; radiological investigations; patients' history, and referral letters. Results The most common clinical feature of nonexposed osteonecrosis was jaw bone pa…
Osteonecrosi dei mascellari da bifosfonati per os: patologia emergente nel management di osteoporosi e malattie dello scheletro. Ritardo diagnostico ed evoluzione di un caso clinico BISPHOSPHONATES PER OS -RELATED OSTEONECROSIS OF THE JAWS: EMERGING COMPLICATION IN THE MANAGEMENT OF OSTEOPOROSIS AND SKELETAL DISEASES. DELAY IN DIAGNOSIS AND NATURAL HISTORY OF A CLINICAL CASE.
Aging and Oral Health: Effects in Hard and Soft Tissues
Changing demographics, including an increase in life expectancy and the growing numbers of elderly has recently focused attention on the need for geriatric dental care. Ageing affects oral tissues in addition to other parts of the human body, and oral health (including oral mucosa, lips, teeth and associated structures, and their functional activity) is an integral component of general health; indeed, oral disease can cause pain, difficulty in speaking, mastication, swallowing, maintaining a balanced diet, not to mention aesthetical considerations and facial alterations leading to anxiety and depression. The World Health Organization recommends the adoption of certain strategies for improvi…
Il tumore a cellule granulari della lingua in un bambino di 7 anni - case report
Bisphosphonate-associated Osteonecrosis of the jaw: frequencies (82 cases) from the Western Sicily-Promab e ARNAS
Storia naturale di ostenecrosi da bifosfonati per os:A case report
Halitosis: could it be more than mere bad breath?
Halitosis is a generic term used to describe unpleasant odor emanating from the mouth air and breath, independent of the source where the odor substances originate. It affects between 50 and 65% of the population, but despite its frequency, this problem is often unaccepted and declared as taboo. Ninety percent of patients suffering from halitosis have oral causes: a small, but important percentage, of oral malodor cases have an extra-oral etiology, very often falling into the category of "blood-borne halitosis". Several systemic diseases have been found to provoke malodor or to be a cofactor; bad breath may be an early sign of a serious local or systemic condition. A psychogenic halitosis a…